Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas

Surgery

Volumn 147, Issue 3, 2010, Pages 405-414

  Tanaka, Shinji ^a   Mogushi, Kaoru ^a   Yasen, Mahmut ^a   Noguchi, Norio ^a   Kudo, Atsushi ^a   Nakamura, Noriaki ^a   Ito, Koji ^a   Miki, Yoshio ^a   Inazawa, Johji ^a   Tanaka, Hiroshi ^a   Arii, Shigeki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA B KINASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; OVERALL SURVIVAL; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL RATE; SURVIVAL TIME; VASCULAR INVASION;

AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; HEPATECTOMY; HEPATIC VEINS; HUMANS; LIVER NEOPLASMS; MALE; MULTIGENE FAMILY; NEOPLASM INVASIVENESS; PHENOTYPE; PORTAL VEIN; RETROSPECTIVE STUDIES;

EID: 76749115120     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.09.037     Document Type: Article

References (32)

1. Ince N., and Wands J.R. The increasing incidence of hepatocellular carcinoma. N Engl J Med 340 (1999) 798-799
2. Arii S., Yamaoka Y., Futagawa S., Inoue K., Kobayashi K., Kojiro M., et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32 (2000) 1224-1229
3. Tanaka S., Noguchi N., Ochiai T., Kudo A., Nakamura N., Ito K., et al. Outdcomes and recurrence of initially resection of hepatocellular carcinoma meeting Milan criteria: rationale for partial hepatectomy as first strategy. J Am Coll Surg 204 (2007) 1-6
4. Kumada T., Nakano S., Takeda I., Sugiyama K., Osada T., Kiriyama S., et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25 (1997) 87-92
5. Izumi R., Shimizu K., Ii T., Yagi M., Matsui O., Nonomura A., et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106 (1994) 720-727
6. Shimada M., Takenaka K., Gion T., Fujiwara Y., Kajiyama K., Maeda T., et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 111 (1996) 720-726
7. Poon R.T., Fan S.T., Lo C.M., Liu C.L., and Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229 (1999) 216-222
8. Ohkubo T., Yamamoto J., Sugawara Y., Shimada K., Yamasaki S., Makuuchi M., et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 191 (2000) 657-660
9. Iizuka N., Oka M., Yamada-Okabe H., Nishida M., Maeda Y., Mori N., et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 361 (2003) 923-929
10. Thomas M.B., and Abbruzzese J.L. Opportunities for targeted therapies in hepatocellular carcinoma. J Clin Oncol 23 (2005) 8093-8108
11. Tanaka S., Arii S., Yasen M., Mogushi K., Su N.T., Zhao C., et al. Aurora kinase B is a predictive factor for aggressive recurrence of hepatocellular carcinoma after curative hepatectomy. Br J Surg 95 (2008) 611-619
12. Dahlquist K.D., Salomonis N., Vranizan K., Lawlor S.C., and Conklin B.R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31 (2002) 19-20
13. Gadea B.B., and Ruderman J.V. Aurora B is required for mitotic chromatin-induced phosphorylation of Op18/Stathmin. Proc Natl Acad Sci U S A 103 (2006) 4493-4498
14. Liu S.T., Rattner J.B., Jablonski S.A., and Yen T.J. Mapping the assembly pathways that specify formation of the trilaminar kinetochore plates in human cells. J Cell Biol 175 (2006) 41-53
15. Ayoub N., Jeyasekharan A.D., Bernal J.A., and Venkitaraman A.R. HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response. Nature 453 (2008) 682-686
16. Chalamalasetty R.B., Hümmer S., Nigg E.A., and Silljé H.H. Influence of human Ect2 depletion and overexpression on cleavage furrow formation and abscission. J Cell Sci 119 (2006) 3008-3019
17. Arii S., Mise M., Harada T., Furutani M., Ishigami S., Niwano M., et al. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology 24 (1996) 316-322
18. Tanaka S., Mori M., Sakamoto Y., Makuuchi M., Sugimachi K., and Wands J.R. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest 103 (1999) 341-345
19. Liu S.H., Lin C.Y., Peng S.Y., Jeng Y.M., Pan H.W., Lai P.L., et al. Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol 160 (2002) 1831-1837
20. Ho M.C., Lin J.J., Chen C.N., Chen C.C., Lee H., Yang C.Y., et al. A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: a microarray approach. Ann Surg Oncol 13 (2006) 1474-1484
21. Kaposi-Novak P., Lee J.S., Gomez-Quiroz L., Coulouarn C., Factor V.M., and Thorgeirsson S.S. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 116 (2006) 1582-1595
22. Nakashima Y., Nakashima O., Tanaka M., Okuda K., Nakashima M., and Kojiro M. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 26 (2003) 142-147
23. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
24. Todo S., and Furukawa H. Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 240 (2004) 451-459
25. Shetty K., Timmins K., Brensinger C., Furth E.E., Rattan S., Sun W., et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 10 (2004) 911-918
26. Shah S.A., Tan J.C., McGilvray I.D., Cattral M.S., Levy G.A., Greig P.D., et al. Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants. J Gastrointest Surg 11 (2007) 464-471
27. Sala M., Fuster J., Llovet J.M., Navasa M., Solé M., Varela M., et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl 10 (2004) 1294-1300
28. Vader G., Medema R.H., and Lens S.M. The chromosomal passenger complex: guiding Aurora-B through mitosis. J Cell Biol 173 (2006) 833-837
29. Takahashi K., Yamada H., and Yanagida M. Fission yeast minichromosome loss mutants mis cause lethal aneuploidy and replication abnormality. Mol Biol Cell 5 (1994) 1145-1158
30. Rajagopalan H., Jallepalli P.V., Rago C., Velculescu V.E., Kinzler K.W., Vogelstein B., et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 428 (2004) 77-81
31. Girdler F., Gascoigne K.E., Eyers P.A., Hartmuth S., Crafter C., Foote K.M., et al. Validating Aurora B as an anti-cancer drug target. J Cell Sci 119 (2006) 3664-3675
32. Aihara A, Tanaka S, Yasen M, Matsumura S, Mitsunori Y, Murakata A, et al. The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma. J Hepatol. In press.